ANDA 85595, held by Watson Laboratories. Methylprednisolone Acetate.
As of Nov 21, 2026, ANDA 85595 (Methylprednisolone Acetate), held by Watson Laboratories, was first approved by FDA on Mar 26, 1979, with 18 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 26, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methylprednisolone Acetate80MG/ML · injectable;injection | Methylprednisolone Acetate | Discontinued |
| Feb 19, 1999 | Supplement 87Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 85Manufacturing | Approved | None posted |
| Nov 18, 1998 | Supplement 84Manufacturing | Approved | None posted |
| Apr 10, 1997 | Supplement 83Manufacturing | Approved | None posted |
| Jun 5, 1996 | Supplement 81Manufacturing | Approved | None posted |
| Sep 1, 1994 | Supplement 77Labeling | Approved | None posted |
| Sep 1, 1994 | Supplement 76Manufacturing | Approved | None posted |
| Mar 15, 1994 | Supplement 75Labeling | Approved | None posted |
| Dec 1, 1992 | Supplement 74Labeling | Approved | None posted |
| Mar 18, 1991 | Supplement 73Labeling | Approved | None posted |
| Nov 13, 1989 | Supplement 72Labeling | Approved | None posted |
| Mar 21, 1989 | Supplement 68Labeling | Approved | None posted |
| Jan 23, 1989 | Supplement 69Manufacturing | Approved | None posted |
| Dec 30, 1988 | Supplement 66Bioequivalence | Approved | None posted |
| Jun 16, 1986 | Supplement 65Manufacturing | Approved | None posted |
| Oct 16, 1984 | Supplement 64Manufacturing | Approved | None posted |
| Oct 16, 1984 | Supplement 63Manufacturing | Approved | None posted |
| Feb 10, 1983 | Supplement 62Manufacturing | Approved | None posted |
| Mar 26, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters